[High Expression of Fragile X Mental Retardation Protein Inhibits Ferroptosis of Colorectal Tumor Cells by Activating the RAS/MAPK Signaling Pathway]

Overview

Journal Nan Fang Yi Ke Da Xue Xue Bao

Specialty General Medicine

Date 2024 Jun 11

PMID 38862446

Authors

N Wang

B Shi

X Man

W Wu

J Cao

Affiliations

Soon will be listed here.

Abstract

Objective: To investigate the mechanism by which fragile X mental retardation protein (FMRP) regulates ferroptosis evasion in colorectal cancer (CRC) cells.

Methods: We examined FMRP expression levels in CRC cell lines using RT-qPCR and Western blotting and analyzed the biological functions and signaling pathways involved in FMRP-mediated regulation of CRC progression using the TCGA database. A lentiviral FMRP overexpression vector (Lv-FMRP) and 3 knockdown vectors (siFMRP-1, siFMRP-2, and siFMRP-3) were constructed, and their effects on proliferation of HCT116 cells were examined using CCK8 assay and plate clone formation assay; the changes in cell ferroptosis level was determined using MDA/ROS/GSH/Fe kits, mitochondrial membrane potential changes were detected using JC-1 fluorescence staining, and the expressions of proteins associated with ferroptosis and the RAS/MAPK signaling pathway were detected using Western blotting. The subcutaneous tumorigenic potential of the transfected cells was evaluated in nude mice.

Results: Compared with normal colonic mucosal epithelial NCM460 cells, the CRC cell lines had significantly higher FMRP expression level. Bioinformatics analysis suggested the involvement of FMRP in regulation of reactive oxygen, oxidative stress-induced cell death, mitochondrial respiration, and glutathione metabolism pathways. In the cell experiments, FMRP knockdown significantly inhibited proliferation of HCT116 cells, lowered cellular GSH content, increased MDA and ROS levels, Fe fluorescence intensity, and mitochondrial membrane potential, and decreased SLC7A11/GPX4 protein expressions and the phosphorylation levels of ERK, MEK, MAPK, and RAS proteins; FMRP overexpression resulted in the opposite changes in the cells. In the tumor-bearing nude mice, HCT116 cells with FMRP knockdown showed attenuated tumorigenic potential with lowered xenograft growth rate and reduced SLC7A11 expression in the xenograft.

Conclusion: The high expression of FMRP inhibits ferroptosis in CRC cells and promotes progression of CRC by activating the RAS/MAPK signaling pathway.

Citing Articles

[DDX5-Targeting Fragile X Mental Retardation Protein Regulates the Wnt/β-catenin Signaling Pathway to Promote Epithelial Mesenchymal Transition in Breast Cancer].

Cao J, Wang J, Shi B, Ma X, Wu W, Wang N Sichuan Da Xue Xue Bao Yi Xue Ban. 2024; 55(5):1138-1149.

PMID: 39507961 PMC: 11536251. DOI: 10.12182/20240960203.

References

Luca R, Averna M, Zalfa F, Vecchi M, Bianchi F, La Fata G . The fragile X protein binds mRNAs involved in cancer progression and modulates metastasis formation. EMBO Mol Med. 2013; 5(10):1523-36. PMC: 3799577. DOI: 10.1002/emmm.201302847. View

Al-Obeed O, El-Obeid A, Matou-Nasri S, Vaali-Mohammed M, Alhaidan Y, Elwatidy M . Herbal melanin inhibits colorectal cancer cell proliferation by altering redox balance, inducing apoptosis, and modulating MAPK signaling. Cancer Cell Int. 2020; 20:126. PMC: 7161222. DOI: 10.1186/s12935-020-01206-x. View

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

Roemhild K, von Maltzahn F, Weiskirchen R, Knuchel R, von Stillfried S, Lammers T . Iron metabolism: pathophysiology and pharmacology. Trends Pharmacol Sci. 2021; 42(8):640-656. PMC: 7611894. DOI: 10.1016/j.tips.2021.05.001. View

Liu X, Hai Y, Dong J, Xu L, Hou W, Su J . Realgar‑induced KRAS mutation lung cancer cell death via KRAS/Raf/MAPK mediates ferroptosis. Int J Oncol. 2022; 61(6). PMC: 9635866. DOI: 10.3892/ijo.2022.5447. View

McGillicuddy L, Fromm J, Hollstein P, Kubek S, Beroukhim R, De Raedt T . Proteasomal and genetic inactivation of the NF1 tumor suppressor in gliomagenesis. Cancer Cell. 2009; 16(1):44-54. PMC: 2897249. DOI: 10.1016/j.ccr.2009.05.009. View

Shamay-Ramot A, Khermesh K, Porath H, Barak M, Pinto Y, Wachtel C . Fmrp Interacts with Adar and Regulates RNA Editing, Synaptic Density and Locomotor Activity in Zebrafish. PLoS Genet. 2015; 11(12):e1005702. PMC: 4670233. DOI: 10.1371/journal.pgen.1005702. View

Shen Z, Liu B, Wu B, Zhou H, Wang X, Cao J . FMRP regulates STAT3 mRNA localization to cellular protrusions and local translation to promote hepatocellular carcinoma metastasis. Commun Biol. 2021; 4(1):540. PMC: 8110961. DOI: 10.1038/s42003-021-02071-8. View

Zeng Q, Saghafinia S, Chryplewicz A, Fournier N, Christe L, Xie Y . Aberrant hyperexpression of the RNA binding protein FMRP in tumors mediates immune evasion. Science. 2022; 378(6621):eabl7207. DOI: 10.1126/science.abl7207. View

10.

Hu Y, Gao Q, Ma S, Yu P, Ding S, Yao X . FMR1 promotes the progression of colorectal cancer cell by stabilizing EGFR mRNA in an mA-dependent manner. Cell Death Dis. 2022; 13(11):941. PMC: 9643526. DOI: 10.1038/s41419-022-05391-7. View

11.

Soleimani A, Rahmani F, Saeedi N, Ghaffarian R, Khazaei M, Ferns G . The potential role of regulatory microRNAs of RAS/MAPK signaling pathway in the pathogenesis of colorectal cancer. J Cell Biochem. 2019; 120(12):19245-19253. DOI: 10.1002/jcb.29268. View

12.

Lei G, Zhang Y, Koppula P, Liu X, Zhang J, Lin S . The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression. Cell Res. 2020; 30(2):146-162. PMC: 7015061. DOI: 10.1038/s41422-019-0263-3. View

13.

Shah S, Molinaro G, Liu B, Wang R, Huber K, Richter J . FMRP Control of Ribosome Translocation Promotes Chromatin Modifications and Alternative Splicing of Neuronal Genes Linked to Autism. Cell Rep. 2020; 30(13):4459-4472.e6. PMC: 7179797. DOI: 10.1016/j.celrep.2020.02.076. View

14.

Hong S, Jeon M, Kwon J, Park H, Lee G, Kim K . Targeting RAF Isoforms and Tumor Microenvironments in RAS or BRAF Mutant Colorectal Cancers with SJ-C1044 for Anti-Tumor Activity. Curr Issues Mol Biol. 2023; 45(7):5865-5878. PMC: 10378394. DOI: 10.3390/cimb45070371. View

15.

Lei G, Mao C, Yan Y, Zhuang L, Gan B . Ferroptosis, radiotherapy, and combination therapeutic strategies. Protein Cell. 2021; 12(11):836-857. PMC: 8563889. DOI: 10.1007/s13238-021-00841-y. View

16.

Casingal C, Kikkawa T, Inada H, Sasaki Y, Osumi N . Identification of FMRP target mRNAs in the developmental brain: FMRP might coordinate Ras/MAPK, Wnt/β-catenin, and mTOR signaling during corticogenesis. Mol Brain. 2020; 13(1):167. PMC: 7739466. DOI: 10.1186/s13041-020-00706-1. View

17.

Sun L, Wang H, Xu D, Yu S, Zhang L, Li X . Lapatinib induces mitochondrial dysfunction to enhance oxidative stress and ferroptosis in doxorubicin-induced cardiomyocytes via inhibition of PI3K/AKT signaling pathway. Bioengineered. 2021; 13(1):48-60. PMC: 8805895. DOI: 10.1080/21655979.2021.2004980. View

18.

Pedini G, Buccarelli M, Bianchi F, Pacini L, Cencelli G, DAlessandris Q . FMRP modulates the Wnt signalling pathway in glioblastoma. Cell Death Dis. 2022; 13(8):719. PMC: 9388540. DOI: 10.1038/s41419-022-05019-w. View

19.

Di Grazia A, Marafini I, Pedini G, Di Fusco D, Laudisi F, Dinallo V . The Fragile X Mental Retardation Protein Regulates RIPK1 and Colorectal Cancer Resistance to Necroptosis. Cell Mol Gastroenterol Hepatol. 2020; 11(2):639-658. PMC: 7806864. DOI: 10.1016/j.jcmgh.2020.10.009. View

20.

Chudy-Onwugaje K, Huang W, Su L, Purdue M, Johnson C, Wang L . Aspirin, ibuprofen, and reduced risk of advanced colorectal adenoma incidence and recurrence and colorectal cancer in the PLCO Cancer Screening Trial. Cancer. 2021; 127(17):3145-3155. PMC: 8355096. DOI: 10.1002/cncr.33623. View